MLH1 and colorectal cancer: The MSI phenotype is not limited to Lynch syndrome, and can be found in approximately 15% of sporadic colorectal cancers, which most frequently show somatic loss of MLH1 due to promoter hyper-methylation, accompanied by a BRAF V600E variant [9].